Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx only, Manufactured by: FDC Limited, Maharashtra, India, Distributed by: Rising Pharmaceuticals, Inc, NJ
Published May 15, 2024 · Recall initiated: April 25, 2024
Summary
FDA records drug Class II recall D-0488-2024, published May 15, 2024 and initiated April 25, 2024. Recalling firm: FDC Limited; Status: Terminated; Reported quantity: 382,104 units; Lot: Lot #: a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.
What to do
Voluntary: Firm initiated · Letter
Get an email if TIMOLOL MALEATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TIMOLOL MALEATE
- Manufacturer
- FDC Limited
- Distributor
- New Jersey Only
- UPC
- 0364980513050
- Lot
- Lot #: a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDATimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited,August 6, 2025
- FDATimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 10mL bottles, Rx only, Manufactured by: FDC Limited,May 14, 2025
- FDATimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited,February 12, 2025
- FDATimolol Maleate Ophthalmic Solution USP, 0.25%, Sterile, 15mL bottles, Rx only, Manufactured by: FDC Limited,December 18, 2024
- FDAtraMADol Hydrochloride Tablets, USP 50 mg, 1000-count bottle, Rx Only, Distributed by: Advagen Pharma Limited,May 15, 2024
- FDATraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count blisterMay 15, 2024
Questions about this recall
Was Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx only, Manufactured by: FDC Limited, Maharashtra, India, Distributed by: Rising Pharmaceuticals, Inc, NJ recalled?
Yes. FDA published recall D-0488-2024 on May 15, 2024. Reported hazard: Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TIMOLOL MALEATE. UPC: 0364980513050.